BMSC550 Pharmacology Exam Prep – Real Practice Questions, Answers
& Detailed Rationales (Updated 2026) | Pharmacokinetics &
Pharmacodynamics, Drug Classes & Mechanisms of Action, Receptor
Interactions, Drug Metabolism & Elimination, Side Effects & Adverse
Reactions, Drug Interactions, Toxicology, Clinical Applications, Dosage
Calculations & Medication Safety
Question 1: What is the primary mechanism by which competitive antagonists
affect receptor activity?
A. They irreversibly bind to the receptor active site
B. They enhance the affinity of agonists for the receptor
C. They bind reversibly to the same site as the agonist, reducing its effect
D. They activate the receptor through an allosteric site
CORRECT ANSWER: C. They bind reversibly to the same site as the agonist,
reducing its effect
Rationale: Competitive antagonists bind reversibly to the orthosteric site of a receptor,
competing with the agonist for binding. This interaction can be overcome by increasing
agonist concentration, resulting in a rightward shift of the dose-response curve without
altering maximal efficacy.
Question 2: Which cytochrome P450 enzyme is primarily responsible for the
metabolism of approximately 50% of clinically used drugs?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C9
CORRECT ANSWER: C. CYP3A4
Rationale: CYP3A4 is the most abundant cytochrome P450 enzyme in the human liver
and intestines, metabolizing approximately half of all prescribed medications, including
statins, calcium channel blockers, and immunosuppressants. Its broad substrate
specificity makes it clinically significant for drug-drug interactions.
Question 3: A drug with a volume of distribution (Vd) of 500 L in a 70 kg adult most
likely exhibits which characteristic?
A. High plasma protein binding
B. Extensive distribution into adipose tissue
C. Limited tissue penetration
D. Rapid renal elimination
CORRECT ANSWER: B. Extensive distribution into adipose tissue
Rationale: A volume of distribution exceeding total body water (~42 L in adults)
indicates extensive tissue distribution. A Vd of 500 L suggests the drug is highly
,lipophilic and sequestered in peripheral tissues such as adipose, rather than remaining
in the plasma compartment.
Question 4: Which pharmacodynamic parameter best describes the concentration
of drug required to produce 50% of the maximal effect?
A. Kd
B. EC50
C. IC50
D. Therapeutic index
CORRECT ANSWER: B. EC50
Rationale: EC50 (half-maximal effective concentration) quantifies drug potency by
representing the concentration needed to achieve 50% of the maximal response in a
dose-response curve. It is distinct from Kd (binding affinity) and IC50 (inhibitory
concentration).
Question 5: Which autonomic receptor subtype mediates bronchodilation when
stimulated by epinephrine?
A. α1-adrenergic
B. α2-adrenergic
C. β1-adrenergic
D. β2-adrenergic
CORRECT ANSWER: D. β2-adrenergic
Rationale: β2-adrenergic receptors are located on bronchial smooth muscle; their
activation by epinephrine or selective agonists (e.g., albuterol) stimulates adenylate
cyclase, increases cAMP, and promotes smooth muscle relaxation, resulting in
bronchodilation.
Question 6: What is the primary mechanism of action of warfarin?
A. Direct inhibition of thrombin
B. Inhibition of vitamin K epoxide reductase
C. Activation of antithrombin III
D. Blockade of platelet ADP receptors
CORRECT ANSWER: B. Inhibition of vitamin K epoxide reductase
Rationale: Warfarin inhibits vitamin K epoxide reductase (VKOR), preventing the
regeneration of reduced vitamin K required for γ-carboxylation of clotting factors II, VII,
IX, and X. This impairs synthesis of functional coagulation factors, producing
anticoagulation.
Question 7: Which drug class is most likely to cause a "cheese reaction" due to
tyramine accumulation?
, A. SSRIs
B. MAO-A inhibitors
C. Beta-blockers
D. ACE inhibitors
CORRECT ANSWER: B. MAO-A inhibitors
Rationale: Monoamine oxidase-A (MAO-A) inhibitors prevent degradation of dietary
tyramine. Accumulated tyramine displaces norepinephrine from synaptic vesicles,
causing acute hypertension, headache, and potential hypertensive crisis—known as
the "cheese reaction."
Question 8: Which pharmacokinetic process is primarily responsible for the first-
pass effect?
A. Renal excretion
B. Hepatic metabolism
C. Pulmonary clearance
D. Biliary excretion
CORRECT ANSWER: B. Hepatic metabolism
Rationale: The first-pass effect occurs when orally administered drugs are extensively
metabolized by the liver (and gut wall) before reaching systemic circulation. Hepatic
cytochrome P450 enzymes and conjugation pathways significantly reduce
bioavailability of susceptible drugs.
Question 9: Which statement best characterizes a drug with high affinity but low
intrinsic activity at a receptor?
A. Full agonist
B. Partial agonist
C. Competitive antagonist
D. Inverse agonist
CORRECT ANSWER: B. Partial agonist
Rationale: Partial agonists bind receptors with high affinity but produce submaximal
response even at full receptor occupancy due to low intrinsic efficacy. They can act as
functional antagonists in the presence of full agonists by occupying receptors without
producing maximal effect.
Question 10: Which antibiotic class inhibits bacterial cell wall synthesis by binding
to penicillin-binding proteins?
A. Aminoglycosides
B. Macrolides
C. β-lactams
D. Tetracyclines
& Detailed Rationales (Updated 2026) | Pharmacokinetics &
Pharmacodynamics, Drug Classes & Mechanisms of Action, Receptor
Interactions, Drug Metabolism & Elimination, Side Effects & Adverse
Reactions, Drug Interactions, Toxicology, Clinical Applications, Dosage
Calculations & Medication Safety
Question 1: What is the primary mechanism by which competitive antagonists
affect receptor activity?
A. They irreversibly bind to the receptor active site
B. They enhance the affinity of agonists for the receptor
C. They bind reversibly to the same site as the agonist, reducing its effect
D. They activate the receptor through an allosteric site
CORRECT ANSWER: C. They bind reversibly to the same site as the agonist,
reducing its effect
Rationale: Competitive antagonists bind reversibly to the orthosteric site of a receptor,
competing with the agonist for binding. This interaction can be overcome by increasing
agonist concentration, resulting in a rightward shift of the dose-response curve without
altering maximal efficacy.
Question 2: Which cytochrome P450 enzyme is primarily responsible for the
metabolism of approximately 50% of clinically used drugs?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C9
CORRECT ANSWER: C. CYP3A4
Rationale: CYP3A4 is the most abundant cytochrome P450 enzyme in the human liver
and intestines, metabolizing approximately half of all prescribed medications, including
statins, calcium channel blockers, and immunosuppressants. Its broad substrate
specificity makes it clinically significant for drug-drug interactions.
Question 3: A drug with a volume of distribution (Vd) of 500 L in a 70 kg adult most
likely exhibits which characteristic?
A. High plasma protein binding
B. Extensive distribution into adipose tissue
C. Limited tissue penetration
D. Rapid renal elimination
CORRECT ANSWER: B. Extensive distribution into adipose tissue
Rationale: A volume of distribution exceeding total body water (~42 L in adults)
indicates extensive tissue distribution. A Vd of 500 L suggests the drug is highly
,lipophilic and sequestered in peripheral tissues such as adipose, rather than remaining
in the plasma compartment.
Question 4: Which pharmacodynamic parameter best describes the concentration
of drug required to produce 50% of the maximal effect?
A. Kd
B. EC50
C. IC50
D. Therapeutic index
CORRECT ANSWER: B. EC50
Rationale: EC50 (half-maximal effective concentration) quantifies drug potency by
representing the concentration needed to achieve 50% of the maximal response in a
dose-response curve. It is distinct from Kd (binding affinity) and IC50 (inhibitory
concentration).
Question 5: Which autonomic receptor subtype mediates bronchodilation when
stimulated by epinephrine?
A. α1-adrenergic
B. α2-adrenergic
C. β1-adrenergic
D. β2-adrenergic
CORRECT ANSWER: D. β2-adrenergic
Rationale: β2-adrenergic receptors are located on bronchial smooth muscle; their
activation by epinephrine or selective agonists (e.g., albuterol) stimulates adenylate
cyclase, increases cAMP, and promotes smooth muscle relaxation, resulting in
bronchodilation.
Question 6: What is the primary mechanism of action of warfarin?
A. Direct inhibition of thrombin
B. Inhibition of vitamin K epoxide reductase
C. Activation of antithrombin III
D. Blockade of platelet ADP receptors
CORRECT ANSWER: B. Inhibition of vitamin K epoxide reductase
Rationale: Warfarin inhibits vitamin K epoxide reductase (VKOR), preventing the
regeneration of reduced vitamin K required for γ-carboxylation of clotting factors II, VII,
IX, and X. This impairs synthesis of functional coagulation factors, producing
anticoagulation.
Question 7: Which drug class is most likely to cause a "cheese reaction" due to
tyramine accumulation?
, A. SSRIs
B. MAO-A inhibitors
C. Beta-blockers
D. ACE inhibitors
CORRECT ANSWER: B. MAO-A inhibitors
Rationale: Monoamine oxidase-A (MAO-A) inhibitors prevent degradation of dietary
tyramine. Accumulated tyramine displaces norepinephrine from synaptic vesicles,
causing acute hypertension, headache, and potential hypertensive crisis—known as
the "cheese reaction."
Question 8: Which pharmacokinetic process is primarily responsible for the first-
pass effect?
A. Renal excretion
B. Hepatic metabolism
C. Pulmonary clearance
D. Biliary excretion
CORRECT ANSWER: B. Hepatic metabolism
Rationale: The first-pass effect occurs when orally administered drugs are extensively
metabolized by the liver (and gut wall) before reaching systemic circulation. Hepatic
cytochrome P450 enzymes and conjugation pathways significantly reduce
bioavailability of susceptible drugs.
Question 9: Which statement best characterizes a drug with high affinity but low
intrinsic activity at a receptor?
A. Full agonist
B. Partial agonist
C. Competitive antagonist
D. Inverse agonist
CORRECT ANSWER: B. Partial agonist
Rationale: Partial agonists bind receptors with high affinity but produce submaximal
response even at full receptor occupancy due to low intrinsic efficacy. They can act as
functional antagonists in the presence of full agonists by occupying receptors without
producing maximal effect.
Question 10: Which antibiotic class inhibits bacterial cell wall synthesis by binding
to penicillin-binding proteins?
A. Aminoglycosides
B. Macrolides
C. β-lactams
D. Tetracyclines
